DA-6886

DB12853InvestigationalSmall molecule

DA-6886 has been used in trials studying the treatment of Irritable Bowel Syndrome.

Chemical structure of DA-6886
Formula / weight
C19H27ClN6O2 · 406.92 g/mol (avg)
Code names
DA-6886

Resolves to

Compound
UNIIJ6388YJ4YRCAS1342815-16-0ChEMBLCHEMBL3950712PubChem54575171
Structure
InChIKeyAULLTYAISZREAX-UHFFFAOYSA-NSMILESCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1CCN(CCCN2C=CN=N2)CC1
Targets
Q13639HTR4

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with DA-6886, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In